Genmab A/S (GMAB) Financial Statements
Genmab A/S financial statements at a glance
Genmab A/S reported revenue of $3.72 billion for fiscal year 2025 (ended December 31, 2025), up 23.9% from fiscal year 2024. Net income was $963.00 million, a net margin of 25.9%.
At the end of fiscal year 2025 it had total assets of $12.87 billion, total liabilities of $7.03 billion and shareholders' equity of $5.85 billion, with cash and short-term investments of $1.72 billion and total debt of $5.43 billion.
Its operations brought in $1.19 billion of cash; capital spending was $55.00 million, leaving free cash flow of $1.13 billion.
The tables below show the income statement, balance sheet and cash flow statement; the key figures of the last 5 fiscal years are at the bottom of the page.
Figures from company filings, in USD; latest fiscal year ended December 31, 2025.
Genmab A/S
Income Statement
Annual • USD
Genmab A/S key figures by fiscal year
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Revenue | $3.7B | $3.0B | $2.4B | $2.1B | $1.3B |
| Gross profit | $3.5B | $2.9B | $2.4B | $2.1B | $1.3B |
| Operating income | $1.3B | $977.0M | $790.0M | $902.0M | $449.6M |
| Net income | $963.0M | $1.1B | $646.1M | $784.7M | $450.2M |
| Diluted EPS | – | $1.69 | $0.98 | $1.20 | $0.69 |
| Total assets | $12.9B | $6.4B | $5.2B | $4.3B | $3.7B |
| Total liabilities | $7.0B | $1.3B | $546.2M | $408.3M | $370.1M |
| Shareholders' equity | $5.8B | $5.1B | $4.7B | $3.9B | $3.4B |
| Cash and short-term investments | $1.7B | $2.9B | $4.2B | $3.2B | $2.9B |
| Total debt | $5.4B | $143.6M | $114.3M | $85.9M | $64.7M |
| Operating cash flow | $1.2B | $1.1B | $1.1B | $563.0M | $339.2M |
| Capital spending | $55.0M | $42.4M | $55.8M | $45.6M | $38.4M |
| Free cash flow | $1.1B | $1.0B | $1.0B | $517.4M | $300.8M |
In USD. Fiscal years as reported by the company; statements on this page go back to fiscal year 2020.
Questions and answers
What was Genmab A/S's revenue in fiscal year 2025?
$3.72 billion, up 23.9% from $3.00 billion in fiscal year 2024.
How much profit does Genmab A/S make?
Genmab A/S reported net income of $963.00 million for fiscal year 2025 (25.9% of revenue); operating income was $1.25 billion.
How much cash and debt does Genmab A/S have?
At the end of fiscal year 2025: cash and short-term investments of $1.72 billion and total debt of $5.43 billion.
What is Genmab A/S's free cash flow?
$1.13 billion in fiscal year 2025 (operating cash flow of $1.19 billion minus capital spending of $55.00 million).
